chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling/cellulitis in her left arm/redness, inflammation, swelling that looked like cellulitis to the arm/deltoid area; redness; to the arm/deltoid area; inflammation; to the arm/deltoid area; swelling/cellulitis in her left arm/swelling; to the arm/deltoid area; This is a spontaneous report from a contactable nurse reported for herself. A 28-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730, expiry date unknown) intramuscular at left deltoid on 16Dec2020 16:45 at single dose for Covid-19 immunization at a hospital facility and not in a military facility. Medical history included ongoing acne. Concomitant medications included ongoing spironolactone for acne. The patient did not receive any other vaccines the day or 4 weeks prior Covid-19 vaccine. The patient informed that after 8 days of getting Covid vaccine she has swelling/cellulitis in her left arm. The patient got the COVID-19 vaccine and had kind of a delayed reaction. She got the vaccine on 16Dec2020 16:45 pm at her workplace. The patient informed that she had no reaction right after the vaccine. On 24Dec2020, the patient experienced redness, inflammation, swelling that looked like cellulitis to the arm/deltoid area. The patient got antibiotics and it has improved. The reporter informed that the events required visit to physician office. The outcome of the events swelling/cellulitis in her left arm/redness, inflammation, swelling that looked like cellulitis to the arm/deltoid area was recovering. The patient was queried regarding seriousness of the events and the patient stated "it could have potentially dangerous." The patient wanted to know if she should get second dose of the vaccine.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events vaccination site cellulitis, vaccination site erythema, vaccination site inflammation and vaccination site swelling cannot be excluded.
20mins p/vax pt exp rash w/itching; started @ ankles progressed to all extremities; chest et stop @ neck by 5PM; took PDH; saw NP given Atarax for rash;  medical exemption for MMR;
blood sugar is out of control/like a roller coaster/blood sugar fluctuates from 50-300mg/dL/has chosen not to get the second dose because of blood sugar issues; This spontaneous case was reported by a patient and describes the occurrence of BLOOD GLUCOSE FLUCTUATION (blood sugar is out of control/like a roller coaster/blood sugar fluctuates from 50-300mg/dL/has chosen not to get the second dose because of blood sugar issues) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN ER) for Diabetes, LISINOPRIL, AMLODIPINE, INSULIN DEGLUDEC (TRESIBA), VITAMIN D [VITAMIN D NOS], ZINC, VITAMIN C [ASCORBIC ACID], FISH OIL and VITAMINS NOS (MULTIPLE VITAMIN) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced BLOOD GLUCOSE FLUCTUATION (blood sugar is out of control/like a roller coaster/blood sugar fluctuates from 50-300mg/dL/has chosen not to get the second dose because of blood sugar issues). At the time of the report, BLOOD GLUCOSE FLUCTUATION (blood sugar is out of control/like a roller coaster/blood sugar fluctuates from 50-300mg/dL/has chosen not to get the second dose because of blood sugar issues) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: TCR added
This is a spontaneous report from a contactable consumer or other non-HCP. A patient, of unspecified age and gender, received the second dose of BNT162B2 (Comirnaty, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Sep 29, 2021, single dose, for COVID-19 immunisation. Medical history not reported. Concomitant medications included patient taking 10 medications. The historical vaccine included the first dose of BNT162B2 (Comirnaty, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Sep 8, 2021, single dose, for COVID-19 immunisation. On an unspecified date Sep 2021, patient had a fever, body ache, red injection area, aching, lumps in armpit area, cold and headache. Patient had the second dose of the vaccine 3 days ago, and still having symptoms. Yesterday, patient had a fever, body ache, red injection area and aching. Patient also patient had lumps in the armpit area, and needed medical attention. The outcome of the events: not recovered. The lot number for the vaccine, BNT162B2, not provided and will be requested during follow-up.
2 1/2-3min p/vax pt began having sz x 31-33seconds;kept pt safe from harm comforted until stabilized;advised to go to MD to be eval;called MD & sent pt over;MD states was not sz was syncope w/tonic clonic movement;had not eaten a/inject;
Patient received a 2nd dose of Moderna after already getting 2 doses of Pfizer. 1st dose of Pfizer on 1/30/21 and 2nd dose of Pfizer on 2/22/21. 1st dose of Moderna on 4/23/21 and 2nd dose of Moderna on 5/21/21.
Fussy, crying, fever (100 degree - 103 degree), Fever lasted 3 days, Treated w/children's Tylenol
pt called 1/13/20 reporting pain in arm, heat and redness, also feeling like areas is crawling, no fever. since injection on 1/7/20. consulted pt to take nsaid, benadry to reduce symptoms, and follow up with pcp if symptom dont resolve after 1-2 days from now. pt mentioned she will ice area as well. and to call us tomorrow to follow up on improvement.
This spontaneous report was received from Registered Nurse, concerning about several children of unknown age and gender. The patients' pertinent medical history, allergies/drug reactions or concomitant drugs were not reported. In JUL-2016, the patients were vaccinated with improperly stored VARIVAX, strength, dose and route of administration were not provided. The nurse reported that the vaccine was exposed to a temperature of 21.9 degrees F and 6.6 degrees F during a period of 4 hours since 10:12 and that this was discovered due to a digital data logger. Additional information has been requested.
HOT, RED, SWOLLEN ARM X3WKS. UNABLE TO LIFT ARM.
Vaccine Administration Error - pt reported last dose of Covid vaccine was 4-2022. Pt requested Bivalent Booster but didnt report to pharmacist that their first Pfizer bivalent booster was 2-20-2023(out of state) . 2nd Pfizer bivalent booster given earlier than 4 month recommendation. This was found after the vaccines were given as the pharmacist was scanning the consent form
Presents to the ER with concern for shortness of breath, vomiting, and chest tightness.  Covid-19:  symptoms started on 1/13, start on remdesivir given.
Pt recvd 1 dose of Engerix-B 8JUL91 for Hep B vax & 2 wks later pt exp inc red & white cell count & felt achy; no treatment given; values declined to upper normal;
1st - arm where given, near elbow severe pain - stiff upper arm - Jan.-thru-July. Nerve like pain. No swelling of shot area. About 10 da., then awoke to legs - that didn't want to move. With help from hands, got out of bed. Extreme weakness for winter - into summer. No fever.
Grandparents state child complained of right leg hurting after getting vaccination and going home.  State within a few days child was stumbling and is just got worse by getting weaker and weaker.  The paralysis progressed up to the right arm and today child states her right eye hurts.  Child is unable to move either extremity on right side.  Grandfather states they took child to facility and were told it was a virus and there was nothing they could do.  Grandparents took child to another facility and they did take an x-ray and are to be seen today again at clinic at 1330.  Child is alert and Grandfather states she has been eating well.  There is no redness or swelling to left leg where vaccination was given.
Patient called clinic on morning of 8/25/15 and stated she developed "hives" on left arm and left hand approximately 3 hours after MMR vaccine administration (3:30 pm on 8/24/15). Patient came to clinic to be evaluated by the physician on duty. She was then referred to Infectious Disease for further evaluation, who cleared her to return to work and stated reaction was of unknown etiology.
Redness appeared at the site of injection. Patient was treated with Cephalexin 500mg. Patient is doing well as of 11-26-2017.
general achiness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (general achiness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MYALGIA (general achiness). At the time of the report, MYALGIA (general achiness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter Treatment information was not provided   This case was linked to MOD-2021-345609 (Patient Link).
Case number PHEH2015US018642 is an initial spontaneous report from a pharmacist received on 17 Sep 2015. This report refers to a patient of an unknown age and gender. The patient was allergic to latex. The patient was accidentally vaccinated with FLUCELVAX, (batch number: 174269) intramuscularly on 17 Sep 2015. No adverse event reported following this medication error (contraindication to vaccination).
I received the vaccine in the early afternoon and started having pain all over my body that evening arount 11:45 pm. The pain was so bad I couldn't sleep. The next morning I started having very bad heart pain. The pain centered on my heart was severe and I was very anxious it could get worse, so I looked up the sympoms of myocarditis. In the afternoon, I was driven to Urgent Care. They refused to see me if it was a reaction to the vaccine. I called another Urgent Care facility and they also refused to see me and told me to go to the emergency room. I was not comfortable going to the emergency room during COVID, so I went home. The pain persisted until the next afternoon of May 10.
Spots that look like bruises have come out on his right hand, between his knuckles and wrist, his left arm - inside forearm and upper abdomen, just below his sternum. He says on his arm it is a cluster of 4-5 splotches that sort of group together and there are some "satellite spots" in the same area. On his sternum it looks like a big circle, yellow and bluish like a bruise. He has not been in any accidents or had any falls. none of the spots are near the injection site itself.
Vaccinated 11 am on 5-5-04. Developed rash on upper arms & thighs that night. Rash mildly pruritic. No meds or treatments by patient. Saw pt. at 10:30 am for evaluation. Started pt on Medrol Dose pak at 2:30 pm. Rash was already fading, with no new areas.
Started with pain at injection site. Now that site hurts a little but it moved down the arm into my elbow and arm above and a little below it. Feels like tendonitis. I asked my doctor if it was the shot or maybe working in my yard. She said probably yard. I am not sure, but I have never had any problem in my arms ever. And the injection site still aches at times. I am icing the elbow/arm and hoping it just goes away. I can use it so I think it will. I am not interested in compensation but want to know if it is the shot so I can avoid this in the future. I did get the flu, it lasted over a week with the nasty nasal drips and I am tired from it more so than ever before and had some mild nausea. Not too bad for a flu though.
Red area around vaccination site, seems to be getting larger. Also seems to be warm to touch. Patient says she feels feverish.
Follow up to FAERS18694343: Patient received casirivimab instead of intended COVID vaccine.  48-hr follow up didn't identify AEs. Patient received COVID vaccine on December 31.
Nausea.Headache, fatigue, muscle aches,body soreness; and  soreness at vaccination site - about 6 hrs later; Two days after vaccine tender to touch left elbow started hurting - later that day I could feel a hard rod-like structure in the elbow on that side >  Two days after vaccine -  whole arm was hurting. Developed Lymphadenopathy.  Fourth day after vaccine: Auxiliary tail of Left breast was hard as well. Called my PCP - warm compresses and Ibuprofen. My arm  - I still feel a hard vein in my left arm. The other symptoms went away after 6 or 7 days. (Although nausea stopped after two days.)
Two hours after vaccine started with headache nonstop, two days later my left ear popped and suddenly got a ringing in the ear causing to lose my hearing,  went to urgent care Dr gave me steroids and antibiotics,  6 days after that(tonight) had to go back to ER cause the symptoms don't get any better still have headache, blood pressure is been high all the time and my hearing is gone and the ear ringing is getting worse and worse, also been very dizzy,  ER gave me prescription for more antibiotics and now I have to see an ear specialist.  Before the shot I was perfect and never got the Covid.
I got symptoms of flu like symptoms with tired, loss of energy, loss of appetite, weakness, and low grade fever. I got a positive COVID-19 test. I went to the hospital and received an antibody infusion. I was also prescribed Pavlovic. My symptoms lasted for 7-10 days. I do feel that the infusion did help. I did call my doctor and did a follow up telehealth visit.
No adverse event/possible Invalid AE; temperature excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (No adverse event/possible Invalid AE) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event/possible Invalid AE) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion). At the time of the report, NO ADVERSE EVENT (No adverse event/possible Invalid AE) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.  The temperature was between 1.8 and 1.7 celsius and then the temperature went up to 3.3 Celsius.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Additional Information received on 30-APR-2021 Include No new significant Information On 04-May-2021: Additional Information received on 4-MAY-2021 In which reporter address updated. Patient initial, gender updated. Possible invalid adverse event was updated.
Patient recieved Pfizer vaccine 01/10/21. On 01/11/21 patient started to experience a migraine. On 01/12/21 patient started to expereince a worsened mirgraine accompanied with vomiting and severe back pain.
Headache, Nausea, Vomiting, Sudden spike High Blood Pressure over 225/110 on 06/26/ & 07/13/2022. Both time admitted in ER then on 06/26 two days as Inpatient and on 07/13/2022 for three days as Inpatient for evaluation, observation and diagnostic checkup.  during hospital admission also done blood tests. After discharge from hospital followup with dr's office and doing diagnostics testing as outpatient. At present recovering at home with medical leave  of absence.
ADACEL administered approx 8:45 AM on 8/22/11. Pt fainted approx 1-minute later.
(L) deltoid injection site swelling/erythema, warmth. Erythema from (L) deltoid traveling down lateral aspect at elbow, (+) fatigue, (+) pruritus. TX: Doxycycline 100 mg po bid x 10 d.
Patient was administered vaccine on 7/7 which had an refrigerator expiration date of 7/2.
PT PRESENTED WITH COMPLAINTS OF N/V AND ABD PAIN X 2hrs POST VACCINATION. PT TREATED WITH PHENERGAN, 1 LITER NS, SIQ X 48 HRS.
Information has been received from a Certified Medical Assistant (C.M.A.) concerning multiple unspecified patients of unknown age and gender. On unknown dates the patients were inadvertently vaccinated with improperly stored RECOMBIVAX HB, lot # K008986 with expiration date 01-APR-2016 (dose and route unspecified), which was exposed to temperature excursion 47.78 Fahrenheit degree (F) for 22 hours 44 minutes or 15 hours. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Admitted here for COVID-19 pneumonia and hypoxemia; tx w/O2, Vit C, steroids, & zinc; weaned to RA; dc'd home
This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE HAEMATOMA (Developed huge hematoma about 5 to 6 inches from the injection the site. The shape of the hematoma was a big square 5 inches by 3 inches then it went to an anchor shape, then it went to the shape of a question mark), CHEST PAIN (Chest pain), MOBILITY DECREASED (Couldn't turn bend or sit down), PAIN (Was in excruciating pain) and FEELING ABNORMAL (Felt like she was in a barrel) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The patient's past medical history included Guillain Barre syndrome (Patient never got the flu shot because of that.) in 1989 and Surgery (Microvalve replacement.). Concurrent medical conditions included Hypothyroidism. Concomitant products included CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) and LEVOTHYROXINE for an unknown indication. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced CHEST PAIN (Chest pain), MOBILITY DECREASED (Couldn't turn bend or sit down), PAIN (Was in excruciating pain) and FEELING ABNORMAL (Felt like she was in a barrel). On an unknown date, the patient experienced VACCINATION SITE HAEMATOMA (Developed huge hematoma about 5 to 6 inches from the injection the site. The shape of the hematoma was a big square 5 inches by 3 inches then it went to an anchor shape, then it went to the shape of a question mark). On 30-Apr-2021, CHEST PAIN (Chest pain), MOBILITY DECREASED (Couldn't turn bend or sit down), PAIN (Was in excruciating pain) and FEELING ABNORMAL (Felt like she was in a barrel) had resolved. At the time of the report, VACCINATION SITE HAEMATOMA (Developed huge hematoma about 5 to 6 inches from the injection the site. The shape of the hematoma was a big square 5 inches by 3 inches then it went to an anchor shape, then it went to the shape of a question mark) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication included Presserarev 2. Events except vaccination site hematoma got worse for about 4 days and started to get better. Reporter states patient might have got the vaccine intravenous instead of intramuscular which might be the reason for huge hematoma. The second dose on the 06-MAY-2021 but could not get it and was rescheduled till  19-MAY-2021.
shakes; Headache; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shakes) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Viral infection.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced TREMOR (shakes) and HEADACHE (Headache). On 24-Feb-2021, HEADACHE (Headache) had resolved. At the time of the report, TREMOR (shakes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Within exactly one month of getting second Moderna Covid 19 shot, I developed Stress Cardio Myopathy
Hair loss started about three weeks after second dose of Moderna vaccine (March 2021) and continued into summer. Lost about 1/4 of hair all over head. Regrowth was noticed in August. Joint pain started about the same time and last about 4 weeks. Also spontaneous bruise/bleeding on hands, legs, back, eye- no trauma associated. I have been referred to a hematologist but cannot get in until April. Did not associate symptoms with vaccine until my brother recently had a reaction to the booster and realized that my symptoms fit the same approximate time line (three weeks after).
The patient started developing lumps around her neck/shoulder, difficulty breathing, pressure on heart, and some arm pain the day after she got vaccination. Since these could be possible side effects from COVID19 vaccines, I recommended her to see her PCP as soon as possible and call 911 if breathing problem/pressure on heart get worse.
I had flu like symptoms, sore throat, coughing, sneezing, and headache. I tested positive for COVID-19 10/18/2022. I had a telehealth visit and they prescribed me PAXLOVID. I started to feel better after taking the medication.
After waiting 10 minutes in the exam room after immunizations were administered, patient and mother left to schedule a follow up appointment. Upon reaching the front desk patient passed out once and regained consciousness, patient proceeded to take a seat and passed out one more time. Patient regained consciousness 1-2 minutes after passing out. Doctor examined her and patient was advised to sit in lobby for 10 minutes and if she did not pass out again she could leave. Patient proceeded to leave after 10 minutes.
Pertussis; This case was reported by a consumer via interactive digital media and described the occurrence of pertussis in a child patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the pertussis was unknown.   It was unknown if the reporter considered the pertussis to be related to DTPa vaccine.  Additional details were provided as follows: The case has been reported by patient's mother. The age at vaccination was not reported. Till the time of reporting, the patient had not received the final TDaP and had contracted. The case was considered as mild because, the patient had been received the vaccination upto the point. This case has been linked with case US2019AMR167031 reported by the same reporter.